Salt effect on solubilization of hydrophobic drugs in block copolymeric micelles and investigation of their in vitro and in vivo oral efficiency

Journal of Drug Delivery Science and Technology

Volumn 39, Issue , 2017, Pages 531-541

  Sheth, Urjita ^a   Nagane, Rajendra ^b   Bahadur, Pratap ^c   Bahadur, Anita ^d  

^a UKA TARSADIA UNIVERSITY   (India)

^b Jai Research Foundation   (India)

^c VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

^d SIR PT Science College   (India)

Author keywords

Caco 2 permeability; Cytotoxicity; Drug release; Pharmacokinetics; Scattering; Tetronics

Indexed keywords

COPOLYMER; CURCUMIN; ETHYLENE OXIDE; PROPYLENE OXIDE; QUERCETIN; SODIUM CHLORIDE;

ADULT; ANIMAL EXPERIMENT; APPARENT PERMEABILITY; AREA UNDER THE CURVE; ARTICLE; CACO-2 CELL LINE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; DRUG DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSPORT; HYDRODYNAMICS; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; IONIC STRENGTH; MAXIMUM PLASMA CONCENTRATION; MICELLE; MICELLIZATION; MTT ASSAY; NEUTRON SCATTERING; NONHUMAN; PARTICLE SIZE; PH; PHOTON CORRELATION SPECTROSCOPY; RAT; SOLUBILIZATION; TEMPERATURE SENSITIVITY; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE DISTRIBUTION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 85019635254     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2017.05.007     Document Type: Article

References (82)

1. Schacher, F.H., Rupar, P.A., Manners, I., Functional block copolymers: nanostructured materials with emerging applications. Angew. Chem. Int. Ed. 51 (2012), 7898–7921.
2. Hu, H., Gopinadhan, M., Osuji, C.O., Directed self-assembly of block copolymers: a tutorial review of strategies for enabling nanotechnology with soft matter. Soft matter 10 (2014), 3867–3889.
3. Hamley, I.W., Developments in Block Copolymer Science and Technology. 2004, Wiley Online Library.
4. Biswas, S., Kumari, P., Lakhani, P.M., Ghosh, B., Recent advances in polymeric micelles for anti-cancer drug delivery. Eur. J. Pharm. Sci. 83 (2016), 184–202.
5. Simões, S.M., Figueiras, A.R., Veiga, F., Concheiro, A., Alvarez-Lorenzo, C., Polymeric micelles for oral drug administration enabling locoregional and systemic treatments. Expert Opin. drug Deliv. 12 (2015), 297–318.
6. Alexandridis, P., Hatton, T.A., Poly (ethylene oxide) poly (propylene oxide) poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloids Surf. A Physicochem. Eng. Asp. 96 (1995), 1–46.
7. Alvarez-Lorenzo, C., Rey-Rico, A., Sosnik, A., Taboada, P., Concheiro, A., Poloxamine-based nanomaterials for drug delivery. Front. Biosci. 2 (2010), 424–440.
8. Chiappetta, D.A., Sosnik, A., Poly (ethylene oxide)–poly (propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur. J. Pharm. Biopharm. 66 (2007), 303–317.
9. Alvarez-Lorenzo, C., Gonzalez-Lopez, J., Fernandez-Tarrio, M., Sandez-Macho, I., Concheiro, A., Tetronic micellization, gelation and drug solubilization: influence of pH and ionic strength. Eur. J. Pharm. Biopharm. 66 (2007), 244–252.
10. Gonzalez-Lopez, J., Alvarez-Lorenzo, C., Taboada, P., Sosnik, A., Sandez-Macho, I., Concheiro, A., Self-associative behavior and drug-solubilizing ability of poloxamine (tetronic) block copolymers. Langmuir 24 (2008), 10688–10697.
11. Bahadur, A., Cabana-Montenegro, S., Aswal, V.K., Lage, E.V., Sandez-Macho, I., Concheiro, A., Alvarez-Lorenzo, C., Bahadur, P., NaCl-triggered self-assembly of hydrophilic poloxamine block copolymers. Int. J. Pharm. 494 (2015), 453–462.
12. ® T904. Colloids Surf. B Biointerf. 83 (2011), 69–77.
13. Perreur, C., Habas, J.-P., Lapp, A., Peyrelasse, J., Salt influence upon the structure of aqueous solutions of branched PEO–PPO–PEO copolymers. Polymer 47 (2006), 841–848.
14. ® T904 in aqueous salt solution. Colloids Surf. A Physicochem. Eng. Asp. 369 (2010), 121–127.
15. ® 1304: investigating the role in solubilizing, release and cytotoxicity of model drugs. J. Mol. Liq. 224 (2016), 303–310.
16. ® T904. J. colloid interface Sci. 351 (2010), 449–456.
17. Parmar, A.V., Bahadur, A., Kuperkar, K., Bahadur, P., PEO–PPO based star-block copolymer T904 as pH responsive nanocarriers for quercetin: solubilization and release study. Eur. Polym. J. 49 (2013), 12–21.
18. Boots, A.W., Haenen, G.R., Bast, A., Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585 (2008), 325–337.
19. Dajas, F., Life or death: neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 143 (2012), 383–396.
20. Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Russo, G.L., The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83 (2012), 6–15.
21. Aggarwal, B.B., Harikumar, K.B., Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 41 (2009), 40–59.
22. Chandran, B., Goel, A., A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. 26 (2012), 1719–1725.
23. Tong, W., Wen, H., Liu, R., Preformulation aspects of insoluble compounds. Water-Insoluble Drug Formul., 2, 2008.
24. Artursson, P., Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorbtive (Caco-2) cells. J. Pharm. Sci. 79 (1990), 476–482.
25. Artursson, P., Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991), 880–885.
26. Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., Leroux, J.-C., Polymeric micelles for oral drug delivery. Eur. J. Pharm. Biopharm. 76 (2010), 147–158.
27. Berne, B.J., Pecora, R., Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics. 2000, Courier Corporation.
28. Aswal, V., Goyal, P., Small-angle neutron scattering diffractometer at Dhruva reactor. Curr. Sci. 79 (2000), 947–953.
29. Augustijns, P.F., Bradshaw, T.P., Gan, L.-S.L., Hendren, R.W., Thakker, D.R., Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporine A transport. Biochem. Biophys. Res. Commun. 197 (1993), 360–365.
30. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. methods 65 (1983), 55–63.
31. Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. methods 119 (1989), 203–210.
32. Hubatsch, I., Ragnarsson, E.G., Artursson, P., Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2 (2007), 2111–2119.
33. Yilmaz, B., Arslan, S., Asci, A., HPLC method for determination of atenolol in human plasma and application to a pharmacokinetic study in Turkey. J. Chromatogr. Sci. 50 (2012), 914–919.
34. Meghana, D., Lahari, K., Kumari, K.S., Prakash, K., Development and validation of RP-HPLC method for simultaneous estimation of Clonazepam and propranolol hydrochloride in bulk and pharmaceutical dosage forms. Invent. Rapid Pharm. Anal. Qual. Assur. 3 (2012), 12–16.
35. Moorthi, C., Kathiresan, K., Simultaneous estimation of curcumin and silibinin using validated RP-HPLC-PDA method and its application in pharmaceutical nanoformulation. Int. J. Pharm. Pharm. Sci. 5 (2013), 475–478.
36. Phani, C.R., Vinaykumar, C., Rao, K., Sindhuja, G., Quantitative analysis of quercetin in natural sources by RP-HPLC. Int. J. Res. Pharm. Biomed. Sci. 1 (2010), 19–22.
37. Gupta, N.K., Nahata, A., Dixit, V.K., Development of a spectrofluorimetric method for the determination of curcumin. Asian J. Trad. Med. 5 (2010), 12–18.
38. S. Srivastava, M. Singh, D. Singh. Development of a spectrofluorimetric method for the determination of quercetin. 亚洲传统医药. 9 136–142.
39. Bayomi, M.A., Al-Angary, A.A., Al-Meshal, M.A., Al-Dardiri, M.M., In vivo evaluation of arteether liposomes. Int. J. Pharm. 175 (1998), 1–7.
40. Dong, J., Chowdhry, B.Z., Leharne, S.A., Solubilisation of polyaromatic hydrocarbons in aqueous solutions of poloxamine T803. Colloids Surf. A Physicochem. Eng. Asp. 246 (2004), 91–98.
41. Dong, J., Armstrong, J., Chowdhry, B.Z., Leharne, S.A., Thermodynamic modelling of the effect of pH upon aggregation transitions in aqueous solutions of the poloxamine, T701. Thermochim. acta 417 (2004), 201–206.
42. González-Gaitano, G., da Silva, M.A., Radulescu, A., Dreiss, C.c.A., Selective tuning of the self-assembly and gelation of a hydrophilic poloxamine by cyclodextrins. Langmuir 31 (2015), 5645–5655.
43. Jain, N.J., Aswal, V., Goyal, P., Bahadur, P., Micellar structure of an ethylene oxide-propylene oxide block copolymer: a small-angle neutron scattering study. J. Phys. Chem. B 102 (1998), 8452–8458.
44. Gadelle, F., Koros, W.J., Schechter, R.S., Solubilization of aromatic solutes in block copolymers. Macromolecules 28 (1995), 4883–4892.
45. Pandit, N., Trygstad, T., Croy, S., Bohorquez, M., Koch, C., Effect of salts on the micellization, clouding, and solubilization behavior of Pluronic F127 solutions. J. colloid interface Sci. 222 (2000), 213–220.
46. Alexandridis, P., Holzwarth, J.F., Differential scanning calorimetry investigation of the effect of salts on aqueous solution properties of an amphiphilic block copolymer (Poloxamer). Langmuir 13 (1997), 6074–6082.
47. Anderson, B.C., Cox, S.M., Ambardekar, A.V., Mallapragada, S.K., The effect of salts on the micellization temperature of aqueous poly (ethylene oxide)-b-poly (propylene oxide)-b-poly (ethylene oxide) solutions and the dissolution rate and water diffusion coefficient in their corresponding gels. J. Pharm. Sci. 91 (2002), 180–188.
48. Bhat, P.A., Rather, G.M., Dar, A.A., Effect of surfactant mixing on partitioning of model hydrophobic drug, naproxen, between aqueous and micellar phases. J. Phys. Chem. B 113 (2009), 997–1006.
49. Ullah, I., Baloch, M.K., Durrani, G.F., Solubility of nonsteroidal anti-inflammatory drugs (NSAIDs) in aqueous solutions of non-ionic surfactants. J. Solut. Chem. 40 (2011), 1341–1348.
50. Barreiro-Iglesias, R., Alvarez-Lorenzo, C., Concheiro, A., Microcalorimetric Evidence and Rheological Consequences of the Salt Effect on Carbopol-surfactant Interactions, Aqueous Polymer—Cosolute Systems. 2003, Springer, 95–102.
51. Collier, A.C., Pritsos, C.A., The mitochondrial uncoupler dicumarol disrupts the MTT assay. Biochem. Pharmacol. 66 (2003), 281–287.
52. Rey-Rico, A., Silva, M., Couceiro, J., Concheiro, A., Alvarez-Lorenzo, C., Osteogenic efficiency of in situ gelling poloxamine systems with and without bone morphogenetic protein-2. Eur. Cell Mater 21 (2011), 317–340.
53. Sosnik, A., Sefton, M.V., Semi-synthetic collagen/poloxamine matrices for tissue engineering. Biomaterials 26 (2005), 7425–7435.
54. Sosnik, A., Leung, B., McGuigan, A.P., Sefton, M.V., Collagen/poloxamine hydrogels: cytocompatibility of embedded HepG2 cells and surface-attached endothelial cells. Tissue Eng. 11 (2005), 1807–1816.
55. Sosnik, A., Leung, B.M., Sefton, M.V., Lactoyl-poloxamine/collagen matrix for cell-containing tissue engineering modules. J. Biomed. Mater. Res. Part A 86 (2008), 339–353.
56. Chiappetta, D.A., Alvarez-Lorenzo, C., Rey-Rico, A., Taboada, P., Concheiro, A., Sosnik, A., N-alkylation of poloxamines modulates micellar assembly and encapsulation and release of the antiretroviral efavirenz. Eur. J. Pharm. Biopharm. 76 (2010), 24–37.
57. Amiji, M.M., Lim Soo, P., Liu, J., Allen, C., Lee, H., Butler, M., Polymeric Micelles for Formulation of Anti-cancer Drugs, Nanotechnology for Cancer Therapy. 2006, CRC Press, 317–355.
58. Delie, F., Rubas, W., A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Reviews™ Ther. Drug Carr. Syst., 14, 1997.
59. Volpe, D., Faustino, P., Yu, L., Hussain, A., Towards standardization of an in vitro method of drug absorption. Pharmacopeial Forum, 2001, 2916–2922.
60. Volpe, D.A., Faustino, P.J., Ciavarella, A.B., Asafu-Adjaye, E.B., Ellison, C.D., Yu, L.X., Hussain, A.S., Classification of drug permeability with a Caco-2 cell monolayer assay. Clin. Res. Regul. Aff. 24 (2007), 39–47.
61. Food, D. Administration, Guidance for Industry: Waiver of in Vivo Bioavailability and Bioequivalence Studies for Immediate-release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. 2000, Food and Drug Administration Rockville, MD.
62. Zhao, Y.H., Le, J., Abraham, M.H., Hersey, A., Eddershaw, P.J., Luscombe, C.N., Boutina, D., Beck, G., Sherborne, B., Cooper, I., Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure–activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 90 (2001), 749–784.
63. Yazdanian, M., Glynn, S.L., Wright, J.L., Hawi, A., Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm. Res. 15 (1998), 1490–1494.
64. Volpe, D.A., Permeability classification of representative fluoroquinolones by a cell culture method. AAPS PharmSci. 6 (2004), 1–6.
65. Jinno, J.-i., Kamada, N., Miyake, M., Yamada, K., Mukai, T., Odomi, M., Toguchi, H., Liversidge, G.G., Higaki, K., Kimura, T., Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. release 111 (2006), 56–64.
66. Rasenack, N., Hartenhauer, H., Müller, B.W., Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm. 254 (2003), 137–145.
67. Maiti, K., Mukherjee, K., Gantait, A., Saha, B.P., Mukherjee, P.K., Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 330 (2007), 155–163.
68. Ravichandran, R., Pharmacokinetic Study of Nanoparticulate Curcumin: Oral Formulation for Enhanced Bioavailability. 2013.
69. Hussain, N., Jaitley, V., Florence, A.T., Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv. drug Deliv. Rev. 50 (2001), 107–142.
70. Stuart, D., Allen, T., A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta (BBA)-Biomembr. 1463 (2000), 219–229.
71. Gursoy, R.N., Benita, S., Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004), 173–182.
72. Lim, S.-J., Lee, M.-K., Kim, C.-K., Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J. Control. release 100 (2004), 53–61.
73. Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (2007), 807–818.
74. Shaikh, J., Ankola, D., Beniwal, V., Singh, D., Kumar, M.R., Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37 (2009), 223–230.
75. Tiyaboonchai, W., Tungpradit, W., Plianbangchang, P., Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337 (2007), 299–306.
76. Manach, C., Texier, O., Morand, C., Crespy, V., Régérat, F., Demigné, C., Rémésy, C., Comparison of the bioavailability of quercetin and catechin in rats. Free Radic. Biol. Med. 27 (1999), 1259–1266.
77. Munjal, B., Pawar, Y.B., Patel, S.B., Bansal, A.K., Comparative oral bioavailability advantage from curcumin formulations. Drug Deliv. Transl. Res. 1 (2011), 322–331.
78. Schmidt, S., Gonzalez, D., Derendorf, H., Significance of protein binding in pharmacokinetics and pharmacodynamics. J. Pharm. Sci. 99 (2010), 1107–1122.
79. Yang, L.-L., Xiao, N., Li, X.-W., Fan, Y., Alolga, R.N., Sun, X.-Y., Wang, S.-L., Li, P., Qi, L.-W., Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS. Sci. Rep., 6, 2016, 35460.
80. Bagad, M., Khan, Z.A., Poly (n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats. Int. J. Nanomed., 10, 2015, 3921.
81. Yordanov, G., Influence of the preparation method on the physicochemical properties of econazole-loaded poly (butyl cyanoacrylate) colloidal nanoparticles. Colloids Surf. A Physicochem. Eng. Asp. 413 (2012), 260–265.
82. Tian, X.-h., Lin, X.-N., Wei, F., Feng, W., Huang, Z.-C., Wang, P., Ren, L., Diao, Y., Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int. J. Nanomed. 6 (2011), 445–452.